Top News

Alios BioPharma Lands $41M In Series B

South San Francisco-based Alios BioPharma said Monday that it has raised $41M in a Series B funding round. The funding came from Novo Ventures, SR One, Roche Venture Fund, and Novartis Ventures. A new, undisclosed investor led the round. Alios BioPharma is led by Lawrence M. Blatt, Ph.D. The company is developing antiviral drugs, initially aimed at influenza and Rhinovirus.


 

Marketplace


blog comments powered by Disqus
 

Latest Headlines

Browse Issues